HealthyDirect · GrowthFit for a long SIP
HSBC Balanced Advantage Fund
HSBC Mutual FundHybrid Schemes - Balanced Advantage Fund/ Dynamic Asset Allocation3.9 years
The scheme seeks to generate long term capital growth and income through investments in equity and equity related securities and fixed income instruments.
- NAV
- 50.4969
- 29 Oct 2026
- 1Y
- -1.6%
- Trailing CAGR
- AUM
- ₹1,474.15 Cr
- 30 Sept 2026
- Volatility
- Low
- 6.6% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Fits if · Peak-to-trough drawdown has stayed shallower than 15%.
Buy checklist
History depth
Watch
3.9 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.15% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -8.7%. Ask whether you can hold through a similar fall.
Vs category
Fail
0% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Mayank Chaturvedi · 1.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 53.3% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 9%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y-1.6%
- 3Y+9.2%
- 5Yn/a
- 10Yn/a
- SI+9.5%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y-0.8%
- 3Y+3.6%
- 5Yn/a
- 10Yn/a
- Since inception
- +9.5%
- Calendar-day CAGR
- Excess 1Y
- +0.6%
- Category median, same plan and option
- 3Y win rate
- 0%
- Windows beating the median
- 3Y percentile
- 45
- Vs comparable share classes
- SIP 3Y XIRR
- +3.6%
- Simulated monthly SIP
- Worst rolling 3Y
- +8.5%
- 227 daily-ending windows
- Median rolling 3Y
- +11.1%
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -8.7%
- Worst peak-to-trough
- Current
- -3.9%
- Below last peak
- Current spell
- 84 days
- Days below latest peak
- Time below peak
- +80%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 9 days
- 63 recovered episodes
- Longest recovery
- 134 days
- Trough to prior peak
11 Dec 2024 – 15 Jul 2025
Trough 3 Mar 2025 · recovered in 134 days
-8.7%
2 Jan 2026 – 6 Jul 2026
Trough 30 Mar 2026 · recovered in 98 days
-7.0%
6 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-5.1%
3 Jun 2024 – 7 Jun 2024
Trough 4 Jun 2024 · recovered in 3 days
-3.2%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
46
Vs category
54
Consistency
19
Risk-adjusted
52
Drawdown
78
Mean
50
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 75 holdings · top 10 are 53.3%.
- Top 5
- 36.9%
- Top 10
- 53.3%
- Largest holding
- 18.3%
- Effective holdings
- 17.7
Cash Margin
Unspecified
18.3%
HDFC Bank Ltd
Financial
5.6%
ICICI Bank Ltd
Financial
4.8%
Axis Bank Ltd
Financial
4.2%
Aurobindo Pharma Ltd
Healthcare
4.1%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Mirae Asset Balanced Advantage Fund
Mirae Asset Mutual Fund
- 1Y
- +0.6%
- 3Y
- +10.2%
- Vol
- 7.1%
- Max DD
- -7.5%
- Sharpe
- 0.63
- 3Y win
- +72%
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility
Axis Balanced Advantage Fund
Axis Mutual Fund
- 1Y
- -1.9%
- 3Y
- +11.5%
- Vol
- 8.2%
- Max DD
- -17.2%
- Sharpe
- 0.47
- 3Y win
- +47%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Baroda BNP Paribas Balanced Advantage Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- -0.5%
- 3Y
- +11.6%
- Vol
- 10.9%
- Max DD
- -20.7%
- Sharpe
- 0.70
- 3Y win
- +99%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Mahindra Manulife Balanced Advantage Fund
Mahindra Manulife Mutual Fund
- 1Y
- -0.8%
- 3Y
- +11.0%
- Vol
- 9.5%
- Max DD
- -9.8%
- Sharpe
- 0.43
- 3Y win
- +93%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Nippon India Balanced Advantage Fund
Nippon India Mutual Fund
- 1Y
- -1.8%
- 3Y
- +10.1%
- Vol
- 11.2%
- Max DD
- -22.8%
- Sharpe
- 0.52
- 3Y win
- +60%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown